Cargando…

Variable Na(v)1.5 Protein Expression from the Wild-Type Allele Correlates with the Penetrance of Cardiac Conduction Disease in the Scn5a (+/−) Mouse Model

BACKGROUND: Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na(+) channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leoni, Anne-Laure, Gavillet, Bruno, Rougier, Jean-Sébastien, Marionneau, Céline, Probst, Vincent, Le Scouarnec, Solena, Schott, Jean-Jacques, Demolombe, Sophie, Bruneval, Patrick, Huang, Christopher L. H., Colledge, William H., Grace, Andrew A., Le Marec, Hervé, Wilde, Arthur A., Mohler, Peter J., Escande, Denis, Abriel, Hugues, Charpentier, Flavien
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824822/
https://www.ncbi.nlm.nih.gov/pubmed/20174578
http://dx.doi.org/10.1371/journal.pone.0009298
Descripción
Sumario:BACKGROUND: Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na(+) channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a mouse model with heterozygous targeted disruption of Scn5a (Scn5a (+/−) mice) and compared our results to those obtained in patients with loss-of-function mutations in SCN5A. METHODOLOGY/PRINCIPAL FINDINGS: Based on ECG, 10-week-old Scn5a (+/−) mice were divided into 2 subgroups, one displaying severe ventricular conduction defects (QRS interval>18 ms) and one a mild phenotype (QRS≤18 ms; QRS in wild-type littermates: 10–18 ms). Phenotypic difference persisted with aging. At 10 weeks, the Na(+) channel blocker ajmaline prolonged QRS interval similarly in both groups of Scn5a (+/−) mice. In contrast, in old mice (>53 weeks), ajmaline effect was larger in the severely affected subgroup. These data matched the clinical observations on patients with SCN5A loss-of-function mutations with either severe or mild conduction defects. Ventricular tachycardia developed in 5/10 old severely affected Scn5a (+/−) mice but not in mildly affected ones. Correspondingly, symptomatic SCN5A–mutated Brugada patients had more severe conduction defects than asymptomatic patients. Old severely affected Scn5a (+/−) mice but not mildly affected ones showed extensive cardiac fibrosis. Mildly affected Scn5a (+/−) mice had similar Na(v)1.5 mRNA but higher Na(v)1.5 protein expression, and moderately larger I(Na) current than severely affected Scn5a (+/−) mice. As a consequence, action potential upstroke velocity was more decreased in severely affected Scn5a (+/−) mice than in mildly affected ones. CONCLUSIONS: Scn5a (+/−) mice show similar phenotypic heterogeneity as SCN5A-mutated patients. In Scn5a (+/−) mice, phenotype severity correlates with wild-type Na(v)1.5 protein expression.